Literature DB >> 25013391

Advances in the management of hepatitis B virus infection.

Hie-Won Hann1.   

Abstract

Entities:  

Year:  2014        PMID： 25013391      PMCID： PMC4080875     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  6 in total

Review 1.  Then and now: the progress in hepatitis B treatment over the past 20 years.

Authors:  Dina Halegoua-De Marzio; Hie-Won Hann
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

2.  Association between nucleoside analogues and risk of hepatitis B virus–related hepatocellular carcinoma recurrence following liver resection.

Authors:  Chun-Ying Wu; Yi-Ju Chen; Hsiu J Ho; Yao-Chun Hsu; Ken N Kuo; Ming-Shiang Wu; Jaw-Town Lin
Journal:  JAMA       Date:  2012-11-14       Impact factor: 56.272

3.  Impact of antiviral therapy on the survival of patients after major hepatectomy for hepatitis B virus-related hepatocellular carcinoma.

Authors:  Albert C Y Chan; Kenneth S H Chok; Wai Key Yuen; See Ching Chan; Ronnie T P Poon; Chung Mau Lo; Sheung Tat Fan
Journal:  Arch Surg       Date:  2011-06

4.  Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection.

Authors:  Tetsuya Hosaka; Fumitaka Suzuki; Masahiro Kobayashi; Yuya Seko; Yusuke Kawamura; Hitomi Sezaki; Norio Akuta; Yoshiyuki Suzuki; Satoshi Saitoh; Yasuji Arase; Kenji Ikeda; Mariko Kobayashi; Hiromitsu Kumada
Journal:  Hepatology       Date:  2013-03-06       Impact factor: 17.425

5.  Trends in waiting list registration for liver transplantation for viral hepatitis in the United States.

Authors:  W Ray Kim; Norah A Terrault; Rachel A Pedersen; Terry M Therneau; Erick Edwards; Andrew A Hindman; Carol L Brosgart
Journal:  Gastroenterology       Date:  2009-07-24       Impact factor: 22.682

6.  A long-term study of the effects of antiviral therapy on survival of patients with HBV-associated hepatocellular carcinoma (HCC) following local tumor ablation.

Authors:  Hie-Won Hann; Robert Coben; Daniel Brown; Laurence Needleman; Ernest Rosato; Albert Min; Richard S Hann; Kyong Bin Park; Stephen Dunn; Anthony J DiMarino
Journal:  Cancer Med       Date:  2014-02-12       Impact factor: 4.452
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.